UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.79 Million Stock Holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 89.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 41,351 shares of the company's stock after purchasing an additional 19,531 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.15% of Establishment Labs worth $1,789,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in ESTA. Hood River Capital Management LLC bought a new stake in Establishment Labs in the 2nd quarter valued at $43,000. Nkcfo LLC bought a new stake in shares of Establishment Labs in the second quarter valued at about $227,000. SG Americas Securities LLC bought a new stake in shares of Establishment Labs in the second quarter valued at about $303,000. Black Swift Group LLC acquired a new stake in Establishment Labs during the third quarter worth about $312,000. Finally, Bay Colony Advisory Group Inc d b a Bay Colony Advisors bought a new position in Establishment Labs during the second quarter valued at about $373,000. Institutional investors and hedge funds own 72.91% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Citigroup boosted their price target on shares of Establishment Labs from $45.00 to $50.00 and gave the company a "neutral" rating in a report on Tuesday, October 1st. BTIG Research increased their price target on shares of Establishment Labs from $62.00 to $65.00 and gave the stock a "buy" rating in a research report on Monday, October 14th. Finally, Stephens upgraded shares of Establishment Labs to a "strong-buy" rating in a research note on Monday, December 2nd. One research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $60.60.

Establishment Labs Trading Down 0.4 %

Shares of ESTA traded down $0.19 during trading hours on Monday, hitting $45.81. 303,164 shares of the stock traded hands, compared to its average volume of 385,808. The business has a fifty day moving average of $43.63 and a 200-day moving average of $44.04. The firm has a market capitalization of $1.28 billion, a PE ratio of -17.76 and a beta of 1.16. Establishment Labs Holdings Inc. has a 1-year low of $22.55 and a 1-year high of $60.12. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.